Lilly to Buy Centessa for OX2R Sleep Drugs Eli Lilly announced acquisition of Centessa on Mar 31, 2026 (Investing.com). Narcolepsy prevalence estimated at ~0.05%; deal terms pending disclosure.

Lilly to Buy Centessa for OX2R Sleep Drugs: Eli Lilly announced acquisition of Centessa on Mar 31, 2026 (Investing.com). Narcolepsy prevalence estimated at ~0.05%; deal terms pending disclosure. 👈 Read full analysis #EliLilly #Centessa #SleepDrugs #Narcolepsy #OX2R